Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Promoting community malaria control in rural Myanmar through an active community participation program using the participatory learning approach.

Maung CN, Sein TT, Hlaing T, Okanurak K, Silawan T, Kaewkungwal J.

Rural Remote Health. 2017 Apr-Jun;17(2):4130. doi: 10.22605/RRH4130. Epub 2017 May 13.

2.

Effectiveness of an Integrated Community- and Clinic-Based Intervention on HIV Testing, HIV Knowledge, and Sexual Risk Behavior of Young Men Who Have Sex With Men in Myanmar.

Aung PP, Ryan C, Bajracharya A, Pasricha N, Thein ZW, Agius PA, Sein TT, Willenberg L, Soe EM, Zaw NT, Tun W, Yam E, Luchters S.

J Adolesc Health. 2017 Feb;60(2S2):S45-S53. doi: 10.1016/j.jadohealth.2016.09.006.

PMID:
28109340
3.

Migrant and Refugee Patient Perspectives on Travel and Tuberculosis along the Thailand-Myanmar Border: A Qualitative Study.

Tschirhart N, Sein T, Nosten F, Foster AM.

PLoS One. 2016 Aug 10;11(8):e0160222. doi: 10.1371/journal.pone.0160222. eCollection 2016.

4.

Challenges of smokeless tobacco use in Myanmar.

Sein T, Swe T, Toe MM, Zaw KK, Sein TO.

Indian J Cancer. 2014 Dec;51 Suppl 1:S3-7. doi: 10.4103/0019-509X.147416. Review.

5.

Smokeless tobacco use in Myanmar.

Kyaing NN, Sein T, Sein AA, Than Htike MM, Tun A, Shein NN.

Indian J Cancer. 2012 Oct-Dec;49(4):347-51. doi: 10.4103/0019-509X.107727. Review.

6.

Influencing factors for household water quality improvement in reducing diarrhoea in resource-limited areas.

Zin T, Mudin KD, Myint T, Naing DKS, Sein T, Shamsul BS.

WHO South East Asia J Public Health. 2013 Jan-Mar;2(1):6-11. doi: 10.4103/2224-3151.115828. Review.

7.

Bowel prolapse following spontaneous rupture of a femoral hernia.

Sein TA, Damodaran A.

Singapore Med J. 2012 Sep;53(9):e182-3.

8.

Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatus.

Stergiopoulou T, Meletiadis J, Sein T, Papaioannidou P, Walsh TJ, Roilides E.

Antimicrob Agents Chemother. 2011 Dec;55(12):5923-9. doi: 10.1128/AAC.00548-11. Epub 2011 Sep 12.

9.

Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis.

Chaturvedi V, Ramani R, Andes D, Diekema DJ, Pfaller MA, Ghannoum MA, Knapp C, Lockhart SR, Ostrosky-Zeichner L, Walsh TJ, Marchillo K, Messer S, Welshenbaugh AR, Bastulli C, Iqbal N, Paetznick VL, Rodriguez J, Sein T.

Antimicrob Agents Chemother. 2011 Apr;55(4):1543-8. doi: 10.1128/AAC.01510-09. Epub 2011 Jan 31.

10.

Effects of immunomodulatory and organism-associated molecules on the permeability of an in vitro blood-brain barrier model to amphotericin B and fluconazole.

Pyrgos V, Mickiene D, Sein T, Cotton M, Fransesconi A, Mizrahi I, Donoghue M, Bundrant N, Kim SY, Hardwick M, Shoham S, Walsh TJ.

Antimicrob Agents Chemother. 2010 Mar;54(3):1305-10. doi: 10.1128/AAC.01263-09. Epub 2009 Dec 7.

11.

Public and/or private health care: tuberculosis patients' perspectives in Myanmar.

Saw S, Manderson L, Bandyopadhyay M, Sein TT, Mon MM, Maung W.

Health Res Policy Syst. 2009 Jul 28;7:19. doi: 10.1186/1478-4505-7-19.

12.

Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis.

Petraitis V, Petraitiene R, Hope WW, Meletiadis J, Mickiene D, Hughes JE, Cotton MP, Stergiopoulou T, Kasai M, Francesconi A, Schaufele RL, Sein T, Avila NA, Bacher J, Walsh TJ.

Antimicrob Agents Chemother. 2009 Jun;53(6):2382-91. doi: 10.1128/AAC.00329-09. Epub 2009 Mar 23.

13.

Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus.

Stergiopoulou T, Meletiadis J, Sein T, Papaioannidou P, Tsiouris I, Roilides E, Walsh TJ.

J Antimicrob Chemother. 2009 Feb;63(2):343-8. doi: 10.1093/jac/dkn473. Epub 2008 Dec 24.

14.

Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis.

Kasai M, Harrington SM, Francesconi A, Petraitis V, Petraitiene R, Beveridge MG, Knudsen T, Milanovich J, Cotton MP, Hughes J, Schaufele RL, Sein T, Bacher J, Murray PR, Kontoyiannis DP, Walsh TJ.

J Clin Microbiol. 2008 Nov;46(11):3690-702. doi: 10.1128/JCM.00917-08. Epub 2008 Sep 24.

15.

Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis.

Hayden R, Pounds S, Knapp K, Petraitiene R, Schaufele RL, Sein T, Walsh TJ.

Pediatr Infect Dis J. 2008 Sep;27(9):815-9. doi: 10.1097/INF.0b013e31817197ab.

16.

In vitro activity of CAY-1, a saponin from Capsicum frutescens, against Microsporum and Trichophyton species.

Stergiopoulou T, De Lucca AJ, Meletiadis J, Sein T, Boue SM, Schaufele R, Roilides E, Ghannoum M, Walsh TJ.

Med Mycol. 2008 Dec;46(8):805-10. doi: 10.1080/13693780802089831.

PMID:
18608885
17.

Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus.

Stergiopoulou T, Meletiadis J, Sein T, Papaioannidou P, Tsiouris I, Roilides E, Walsh TJ.

Antimicrob Agents Chemother. 2008 Jun;52(6):2196-204. doi: 10.1128/AAC.00735-07. Epub 2008 Feb 25.

18.

Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei.

Chaturvedi V, Ramani R, Ghannoum MA, Killian SB, Holliday N, Knapp C, Ostrosky-Zeichner L, Messer SA, Pfaller MA, Iqbal NJ, Arthington-Skaggs BA, Vazquez JA, Sein T, Rex JH, Walsh TJ.

Antimicrob Agents Chemother. 2008 Apr;52(4):1500-2. doi: 10.1128/AAC.00574-07. Epub 2008 Jan 28.

19.

Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia.

Antachopoulos C, Meletiadis J, Sein T, Roilides E, Walsh TJ.

Antimicrob Agents Chemother. 2008 Jan;52(1):321-8. Epub 2007 Oct 15.

20.

Zygomycosis in children: a systematic review and analysis of reported cases.

Zaoutis TE, Roilides E, Chiou CC, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Prasad PA, Chu JH, Walsh TJ.

Pediatr Infect Dis J. 2007 Aug;26(8):723-7. Review.

PMID:
17848885
21.

Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy.

Hope WW, Kruhlak MJ, Lyman CA, Petraitiene R, Petraitis V, Francesconi A, Kasai M, Mickiene D, Sein T, Peter J, Kelaher AM, Hughes JE, Cotton MP, Cotten CJ, Bacher J, Tripathi S, Bermudez L, Maugel TK, Zerfas PM, Wingard JR, Drusano GL, Walsh TJ.

J Infect Dis. 2007 Feb 1;195(3):455-66. Epub 2006 Dec 21.

PMID:
17205486
22.

Use of high inoculum for early metabolic signalling and rapid susceptibility testing of Aspergillus species.

Antachopoulos C, Meletiadis J, Sein T, Roilides E, Walsh TJ.

J Antimicrob Chemother. 2007 Feb;59(2):230-7. Epub 2006 Dec 21.

PMID:
17185296
23.

Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species.

Antachopoulos C, Meletiadis J, Sein T, Roilides E, Walsh TJ.

Antimicrob Agents Chemother. 2007 Mar;51(3):881-7. Epub 2006 Dec 4.

24.

Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations.

Groll AH, Lyman CA, Petraitis V, Petraitiene R, Armstrong D, Mickiene D, Alfaro RM, Schaufele RL, Sein T, Bacher J, Walsh TJ.

Antimicrob Agents Chemother. 2006 Oct;50(10):3418-23.

25.

Triazole-polyene antagonism in experimental invasive pulmonary aspergillosis: in vitro and in vivo correlation.

Meletiadis J, Petraitis V, Petraitiene R, Lin P, Stergiopoulou T, Kelaher AM, Sein T, Schaufele RL, Bacher J, Walsh TJ.

J Infect Dis. 2006 Oct 1;194(7):1008-18. Epub 2006 Aug 28.

PMID:
16960790
26.

Relationship between metabolism and biomass of medically important zygomycetes.

Antachopoulos C, Meletiadis J, Roilides E, Sein T, Sutton DA, Wickes BL, Rinaldi MG, Merz WG, Shea YR, Walsh TJ.

Med Mycol. 2006 Aug;44(5):429-38.

PMID:
16882609
27.

Multidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis.

Petraitis V, Petraitiene R, Solomon J, Kelaher AM, Murray HA, Mya-San C, Bhandary AK, Sein T, Avila NA, Basevicius A, Bacher J, Walsh TJ.

Antimicrob Agents Chemother. 2006 Apr;50(4):1510-7.

28.

Rapid susceptibility testing of medically important zygomycetes by XTT assay.

Antachopoulos C, Meletiadis J, Roilides E, Sein T, Walsh TJ.

J Clin Microbiol. 2006 Feb;44(2):553-60.

29.

Use of quantitative real-time PCR to study the kinetics of extracellular DNA released from Candida albicans, with implications for diagnosis of invasive Candidiasis.

Kasai M, Francesconi A, Petraitiene R, Petraitis V, Kelaher AM, Kim HS, Meletiadis J, Sein T, Bacher J, Walsh TJ.

J Clin Microbiol. 2006 Jan;44(1):143-50.

30.

Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ.

Clin Infect Dis. 2005 Sep 1;41(5):634-53. Epub 2005 Jul 29. Review.

PMID:
16080086
31.

Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans.

Kim HS, Choi EH, Khan J, Roilides E, Francesconi A, Kasai M, Sein T, Schaufele RL, Sakurai K, Son CG, Greer BT, Chanock S, Lyman CA, Walsh TJ.

Infect Immun. 2005 Jun;73(6):3714-24.

32.

Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits.

Petraitiene R, Petraitis V, Kelaher AM, Sarafandi AA, Mickiene D, Groll AH, Sein T, Bacher J, Walsh TJ.

Antimicrob Agents Chemother. 2005 May;49(5):2084-92.

33.

Saliva affects the antifungal activity of exogenously added histatin 3 towards Candida albicans.

Yamagishi H, Fitzgerald DH, Sein T, Walsh TJ, O'Connell BC.

FEMS Microbiol Lett. 2005 Mar 1;244(1):207-12.

34.

Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction.

Walsh TJ, Shoham S, Petraitiene R, Sein T, Schaufele R, Kelaher A, Murray H, Mya-San C, Bacher J, Petraitis V.

J Clin Microbiol. 2004 Oct;42(10):4744-8.

35.

Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans.

Petraitis V, Petraitiene R, Kelaher AM, Sarafandi AA, Sein T, Mickiene D, Bacher J, Groll AH, Walsh TJ.

Antimicrob Agents Chemother. 2004 Oct;48(10):3959-67.

36.

Anaerobic nitrogen-fixing consortia consisting of clostridia isolated from gramineous plants.

Minamisawa K, Nishioka K, Miyaki T, Ye B, Miyamoto T, You M, Saito A, Saito M, Barraquio WL, Teaumroong N, Sein T, Sato T.

Appl Environ Microbiol. 2004 May;70(5):3096-102.

37.

Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.

Walsh TJ, Petraitis V, Petraitiene R, Field-Ridley A, Sutton D, Ghannoum M, Sein T, Schaufele R, Peter J, Bacher J, Casler H, Armstrong D, Espinel-Ingroff A, Rinaldi MG, Lyman CA.

J Infect Dis. 2003 Jul 15;188(2):305-19. Epub 2003 Jul 9.

PMID:
12854088
38.

Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin.

Petraitis V, Petraitiene R, Sarafandi AA, Kelaher AM, Lyman CA, Casler HE, Sein T, Groll AH, Bacher J, Avila NA, Walsh TJ.

J Infect Dis. 2003 Jun 15;187(12):1834-43. Epub 2003 Jun 4.

PMID:
12792859
39.

Macrophage colony-stimulating factor enhances phagocytosis and oxidative burst of mononuclear phagocytes against Penicillium marneffei conidia.

Roilides E, Lyman CA, Sein T, Petraitiene R, Walsh TJ.

FEMS Immunol Med Microbiol. 2003 May 15;36(1-2):19-26.

40.

Amphotericin B formulations exert additive antifungal activity in combination with pulmonary alveolar macrophages and polymorphonuclear leukocytes against Aspergillus fumigatus.

Roilides E, Lyman CA, Filioti J, Akpogheneta O, Sein T, Lamaignere CG, Petraitiene R, Walsh TJ.

Antimicrob Agents Chemother. 2002 Jun;46(6):1974-6.

41.

Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits.

Petraitis V, Petraitiene R, Groll AH, Roussillon K, Hemmings M, Lyman CA, Sein T, Bacher J, Bekersky I, Walsh TJ.

Antimicrob Agents Chemother. 2002 Jun;46(6):1857-69.

42.

A role for focal adhesion kinase in hyluronan-dependent MMP-2 secretion in a human small-cell lung carcinoma cell line, QG90.

Zhang Y, Thant AA, Hiraiwa Y, Naito Y, Sein TT, Sohara Y, Matsuda S, Hamaguchi M.

Biochem Biophys Res Commun. 2002 Jan 25;290(3):1123-7.

PMID:
11798192
43.

Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia.

Petraitiene R, Petraitis V, Groll AH, Sein T, Schaufele RL, Francesconi A, Bacher J, Avila NA, Walsh TJ.

Antimicrob Agents Chemother. 2002 Jan;46(1):12-23.

44.

Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells.

Thant AA, Nawa A, Kikkawa F, Ichigotani Y, Zhang Y, Sein TT, Amin AR, Hamaguchi M.

Clin Exp Metastasis. 2000;18(5):423-8.

PMID:
11467775
45.

Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.

Petraitiene R, Petraitis V, Groll AH, Sein T, Piscitelli S, Candelario M, Field-Ridley A, Avila N, Bacher J, Walsh TJ.

Antimicrob Agents Chemother. 2001 Mar;45(3):857-69.

46.

Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.

Petraitis V, Petraitiene R, Groll AH, Sein T, Schaufele RL, Lyman CA, Francesconi A, Bacher J, Piscitelli SC, Walsh TJ.

Antimicrob Agents Chemother. 2001 Feb;45(2):471-9.

47.

Elevated serum concentrations of interleukin-10 in nonneutropenic patients with invasive aspergillosis.

Roilides E, Sein T, Roden M, Schaufele RL, Walsh TJ.

J Infect Dis. 2001 Feb 1;183(3):518-20. No abstract available.

PMID:
11133388
48.

A role for FAK in the Concanavalin A-dependent secretion of matrix metalloproteinase-2 and -9.

Sein TT, Thant AA, Hiraiwa Y, Amin AR, Sohara Y, Liu Y, Matsuda S, Yamamoto T, Hamaguchi M.

Oncogene. 2000 Nov 16;19(48):5539-42.

49.

Dose-dependent pharmacokinetics of amphotericin B lipid complex in rabbits.

Walsh TJ, Jackson AJ, Lee JW, Amantea M, Sein T, Bacher J, Zech L.

Antimicrob Agents Chemother. 2000 Aug;44(8):2068-76. Erratum in: Antimicrob Agents Chemother 2000 Oct;44(10):2924.

50.

Supplemental Content

Support Center